☰

Alex C. Kim, Ph.D. - Publications

Affiliations: 
2009 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Molecular Biology, Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD. Adrenocortical carcinoma. Endocrine Reviews. 35: 282-326. PMID 24423978 DOI: 10.1210/er.2013-1029  0.533
2012 Heaton JH, Wood MA, Kim AC, Lima LO, Barlaskar FM, Almeida MQ, Fragoso MC, Kuick R, Lerario AM, Simon DP, Soares IC, Starnes E, Thomas DG, Latronico AC, Giordano TJ, et al. Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin. The American Journal of Pathology. 181: 1017-33. PMID 22800756 DOI: 10.1016/J.Ajpath.2012.05.026  0.64
2010 Watson RL, Spalding AC, Zielske SP, Morgan M, Kim AC, Bommer GT, Eldar-Finkelman H, Giordano T, Fearon ER, Hammer GD, Lawrence TS, Ben-Josef E. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer. Neoplasia (New York, N.Y.). 12: 357-65. PMID 20454507 DOI: 10.1593/Neo.92112  0.548
2009 Else T, Trovato A, Kim AC, Wu Y, Ferguson DO, Kuick RD, Lucas PC, Hammer GD. Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell. 15: 465-76. PMID 19477426 DOI: 10.1016/J.Ccr.2009.04.011  0.545
2009 Kim AC, Barlaskar FM, Heaton JH, Else T, Kelly VR, Krill KT, Scheys JO, Simon DP, Trovato A, Yang WH, Hammer GD. In search of adrenocortical stem and progenitor cells. Endocrine Reviews. 30: 241-63. PMID 19403887 DOI: 10.1210/Er.2008-0039  0.556
2009 Kim A, Giordano TJ, Kuick R, Serecky K, Hammer GD. Wnt/betacatenin signaling in adrenocortical stem/progenitor cells: implications for adrenocortical carcinoma. Annales D'Endocrinologie. 70: 156. PMID 19286162 DOI: 10.1016/J.Ando.2009.02.006  0.639
2009 Barlaskar FM, Spalding AC, Heaton JH, Kuick R, Kim AC, Thomas DG, Giordano TJ, Ben-Josef E, Hammer GD. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism. 94: 204-12. PMID 18854392 DOI: 10.1210/Jc.2008-1456  0.636
2008 Kim AC, Reuter AL, Zubair M, Else T, Serecky K, Bingham NC, Lavery GG, Parker KL, Hammer GD. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development (Cambridge, England). 135: 2593-602. PMID 18599507 DOI: 10.1242/Dev.021493  0.574
2007 Kim AC, Hammer GD. Adrenocortical cells with stem/progenitor cell properties: recent advances. Molecular and Cellular Endocrinology. 265: 10-6. PMID 17240045 DOI: 10.1016/J.Mce.2006.12.028  0.624
Show low-probability matches.